Analysis of Adherence in Subjects Undergoing Differin Gel, 0.1% Treatment of Moderate to Severe Acne Vulgaris
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to investigate potential differences between four
treatment intervention groups in the adherence to treatment with Differin® Gel, 0.1%.
Differin is approved by the Food and Drug Administration (FDA) to treat acne.